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Background: To investigate the feasibility of monitoring quality of life (QL) with cystic fibrosis (CF) in a clinical setting, to explore
changes in subjective health and to describe the impact of multiple medical and psychosocial factors on the patients' QL.
Methods: 108 adolescent and adult outpatients (age 15–47years, FEV1 20–125% of the predicted) answered the Questions on Life
Satisfaction repeatedly parallel to each pulmonary function test (2–16 assessments per patient within 18 months). Multiple regression
analysis determined the contribution of medical and psychosocial factors to the patients' QL.
Results: Good acceptance of the instrument was observed. The completion time was between 5 and 29 min per assessment (median 11 min).
QL remained quite stable (rtt = .69) with the previous QL score predicting most of the variance of the present score. Additionally, a longer
interval between assessments, new colonization with Pseudomonas aeruginosa, infection exacerbations, partnership, vocation and living
separately from parents significantly predicted QL at the second assessment. Pulmonary function varied independently of QL.
Conclusions: Medical factors such as pulmonary exacerbation and social living circumstances have an impact on the QL of patients with
CF. Repeated QL assessments in clinical routine are feasible and useful to recognize the individual patient's adaptation to the disease.
© 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Adolescents and adults; Cystic fibrosis; Life satisfaction; Longitudinal assessment; Psychosocial aspects; Quality of life1. Introduction
Although quality of life (QL) is considered increasingly
important in chronic conditions, there is a lack of prospective
longitudinal studies and clinical trials involving QL with
cystic fibrosis (CF) [2–4]. Therefore, the knowledge of
changes in patients' subjective health and its determinants is
limited. So far, monitoring QL in clinical practice is mostly
done routinely by the “How are you?” question. The use of
standardized psychometric instruments is still limited,Abbreviations: ANOVAR, repeated measures analysis of variance; BMI,
body mass index; CF, cystic fibrosis; FEV1, forced expiratory volume in one
second; FLZM, Questions on Life Satisfaction; FLZM-CF, Questions on Life
Satisfaction, disease-specific module for CF; QL, quality of life.
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doi:10.1016/j.jcf.2006.06.005although several disease-specific instruments have been
developed over the past ten years [5–9]. Lack of staff trained
in applied psychometrics and limited practicability of these
instruments may be responsible for the abstinence from
structured routine assessment of QL in clinical practice.
With regard to its definition as a multi-dimensional mea-
sure integrating self-reported physical, emotional and social
functioning and well-being [10], QL is a dynamic psycho-
logical construct, which describes the subjective health per-
ception of the patients independently of objective health
parameters [11]. QL scores reflect the impact of disease-
related stressors and other life stressors in relation to the
psychological adaptation of the individual [12]. Patients may
maintain good QL in spite of being seriously ill, and other
patients may report a bad QL although they have a mild
manifestation of the disease [13,14].
There is an ongoing discussion on the best way of mea-
suring QL in CF [9,15,28]. Some questionnaires such as theed by Elsevier B.V. All rights reserved.
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the generic SF-36 [6] assess primarily the patients' percep-
tions of their functional health. The Questions on Life Sat-
isfaction (FLZM) have been proposed as a reliable and valid
instrument to reflect the subjective perspective of the patient
by considering the importance and satisfaction ratings by the
individual for different life domains [7]. So far, the FLZM
has been used in a study with CF patients evaluating the
effectiveness of inpatient rehabilitation programmes [16],
but the feasibility of the FLZ in an outpatient setting has not
yet been demonstrated. Therefore a purpose of the present
study is to demonstrate the feasibility of repeated QL assess-
ments in clinical routine. Feasibility in clinical routine is
dependent on the practicability of the instrument, for ex-
ample by its shortness, its costs, and its easiness of data
collection and analysis. We assessed feasibility by observing
the acceptance of repeated assessments by patients and pro-
fessionals, by the proportion of missing data, and by mea-
suring the time needed to fill in the instrument.
Another area of interest is the identification of factors
impacting on patients' QLwith CF.Multiple factors have been
analysed, but the findings are only partially consistent. The
following aspects have been reported to correlate with QL in
CF patients: socio-demographic factors such as age [17,18]
and gender [9,18–21]; cultural background [22]; disease fac-
tors such as pulmonary function [5,7,14,17,20,21,23–25],
infection [19,26,27], bodymass index [5,20,28], or concurrent
medical conditions [26]; treatment factors such as intra-venous
[29] or inhalative therapy with antibiotic drugs [25,30], re-
combinant human DNase [17], hospital admission [17,27],
heart and lung transplantation [21,31], daily time for therapy
[32], and the number of different medications [26]; and psy-
chosocial factors such as work status [33], coping with the
disease [12], psychopathology, hope for the future and family
functioning [34]. However, most of the findings are based on
cross-sectional studies and cannot estimate determinants of
changes in QL. Only few prospective longitudinal studies with
QL as the primary variable have been done so far. Based on
multiple regression analysis, Bradley et al. [29] reported that
changes in exercise capacity and sputum output contrib-
uted significantly to changes in QL. With the same method,
Johnson et al. [17] found that only previous scores of QL and
the number of hospital admissions showed a substantial quan-
titative association with QL. In another longitudinal QL study,
Kotwicki et al. [26] found that changes in QL were associated
with changes in the number of respiratory infections, changes
in the number of concurrent medical conditions, and changes
in different medications. Vermeulen et al. [31] showed im-
provements in QL after heart lung transplantation, and in a
study of the course of QL during pulmonary exacerbations Yi
et al. [27] reported that hospitalization was associated with an
improvement in psychosocial QL by the post-exacerbation
assessment.
Most of the QL research with CF patients is based on
cross-sectional clinical studies with selected samples of
participants. It is not clear whether these results can begeneralized to the average CF population. The only com-
munity-based longitudinal survey study by Sawyer et al.
[35,36] followed up 123 children and adolescents with CF
for two years and found a stagnation of QL as measured by
the Child Health Questionnaire. However, to our knowledge
a clinic-based naturalistic approach to measuring QL in CF
has never been done. Therefore the purpose of the present
study was to include a non-selective sample of typical
patients attending outpatient CF clinics in Germany and
follow them up by repeated QL assessments. In accordance
with the previous findings in the literature, this study ex-
plores multiple determinants of QL with CF and investigates
intra-individual changes of QL in a naturalistic design of
outpatient treatment. The following explorative research
questions are addressed:
1. How stable is quality of life with CF under naturalistic
conditions of outpatient treatment? Inwhich domains ofQL
is there a higher or lower extent of intra-individual change?
2. Which factors out of a broad range of psychosocial, socio-
demographic, medical and treatment factors have a
significant impact on QL with CF? Are changes in health
condition as a decrease in pulmonary function or pul-
monary exacerbations correlated with changes in QL, and
to what extent is QL determined by different factors?
2. Methods
2.1. Study design
The study took place in four German outpatient CF
centres. All patients with a minimum age of 15 years were
asked to participate. Informed consent of adult patients and of
legal guardians of adolescent patients, and informed assent of
adolescents themselves were acquired according to the
guidelines of the local medical committee. In a prospective
longitudinal approach, QLwas assessed repeatedly parallel to
each pulmonary function test during the observational period
of 18 months. Forced expiratory volume in one second as a
percentage of the predicted value (FEV1%), body mass index
(BMI), infection parameters, antibiotic i.v. therapy within the
four weeks prior to assessment, socio-demographic data and
psychosocial living circumstances such as partnership status,
vocation and housing were recorded at each QL assessment.
The interval between the assessments depended on the
standards of routine monitoring of pulmonary function (1–4
times per year), on the patients' compliance with these stan-
dards, or on specific clinical indications, for example in the
case of pulmonary exacerbation. Therefore the interval
between the assessments varied from 1 to 405 days with a
median of 86 and a standard deviation of 66 days.
2.2. Participants
148 patients were enrolled in the study with a total of 460
assessments. All patients were Caucasians. 108 patients were
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provided only baseline data because they appeared only once
in their CF centre during the course of the study. For details
of the study sample see Table 1.
2.3. Instruments
The Questions on Life Satisfaction FLZM are a multi-
dimensional instrument measuring general life satisfaction,
satisfaction with health, and satisfaction with CF-specific
aspects of life. The FLZM was originally developed as a
multi-dimensional generic questionnaire [37], which allows
the respondent to weight her/his satisfaction with each of the
16 domains of daily life in relation to her/his subjective
importance of each domain. Eight general dimensions of life
satisfaction are measured: Friends/acquaintances, leisure
time/hobbies, general health, income/financial security, oc-
cupation/work, housing/living conditions, family life/chil-
dren and partner relationship/sexuality. Eight dimensions
are health-related without reference to disease-specific prob-
lems: Physical condition/fitness, ability to relax, energy/zest
for life, mobility, vision and hearing, freedom from anxiety,
freedom from aches and pain, and independence from
help/care. An additional disease-specific module [7] com-
prises nine CF-specific life dimensions: breathing difficul-
ties/cough, abdominal pain/digestive trouble, eating, sleep,
integration of therapy into daily routine, adherence to
therapy, understanding by others, being needed by others,
and disadvantage because of CF. First, the respondent rates
her/his subjective importance of each dimension on scales
between 1 (not important) to 5 (extremely important). Sec-
ond, the present satisfaction with each of these dimensions is
rated, again on 1–5 scales (1=dissatisfied, 5=very satisfied).
The weighted scores are calculated by the formula weighted
satisfaction=(importance rating −1)×[(2× satisfaction rat-
ing)−5]. Three sum-scores can be computed adding theTable 1
Sample description (N=108)
Variable
Age (years) Mean 27.0, range 15–47, SD=7.9
Gender 54% female
Education 29%b9 school years
71%N9 school years
Vocation 42% full-time
11% part-time
47% no vocation
Housing 37% with parents
63% own household
Economic situation 63% independent
37% dependent
FEV1% Mean=62.6, SD=26.2, range 20–125
BMI Mean=20.5, SD=2.5, range 13.5–26.9
Time for daily therapy (h) Median=1.5, range .17–8.0
Pseudomonas aeruginosa
colonization
84%
Burkholderia cepacia colonization 5.6%
Oxygen substitution 14%eight health-related, the eight general satisfaction, and the
nine CF-specific scores. A total life-satisfaction score is
derived by adding all 26 weighted satisfaction scores. For
further details of the measurement concept and the psy-
chometric properties of the FLZM see Goldbeck et al. [7].
The questionnaire is available from the authors.
The patients answered the FLZM during their visit to the
outpatient clinic. In two thirds of the assessments the ques-
tions were administered by a laptop computer, in one third
the paper-and-pencil version was used. The use of the paper–
pencil questionnaire was due to the inconsistent training of
staff members in using the computer system, and due to the
inconsistent availability of hardware. We included paper–
pencil questionnaires as a substitute to reduce missing data
that would have occurred if we had used computer-admin-
istered assessments only. Comparisons of the scores by mo-
dality of assessment revealed a statistical tendency to report
lower scores in the paper–pencil version in some domains,
but these differences were not significant and could therefore
be neglected in the further analyses. The advantage of the
computer-version would be to provide an immediate analysis
of the results for the patient and the therapists, but this feature
was not used in our study for technical reasons in several CF
centres. Good reliability and validity of the FLZM have been
previously reported [7,37,38]. The reliability scores (Cron-
bach's α) in the current study ranged from .73 for the gen-
eral life satisfaction module and .83 for the health-related
life satisfaction module, indicating sufficient internal con-
sistency of the scales. The QL sum-score (across all life
domains) had a good reliability with α=.92.
The following medical parameters were taken from the
charts: present pulmonary function (per cent of the predicted
FEV1), body mass index (BMI), colonization status with
Pseudomonas aeruginosa and Burkolderia cepacia, recent i.v.
antibiosis (in the past 4 weeks), current oxygen therapy, and
exacerbation of pulmonary infection at the time of assessment
according to the clinical judgement of the physician. Socio-
demographic data and time for daily therapy were recorded by
the patients in an additional questionnaire.
2.4. Statistical analyses
Weighted satisfaction scores were calculated for each life
domain, and their intra-individual variance was determined
by paired comparisons between the QL scores at the first and
second assessments of each patient. All weighted satisfaction
scores were normally distributed. Feasibility was tested by
acceptance rates for the repeated assessments by the patients
(vs. dropout of patients refusing repeated assessments), by
the proportion of missing data, and by the time needed to
answer the questions. The relation of changes of pulmonary
function and changes of QL was analysed using Pearson
correlations between intra-individual difference scores. This
procedure allows inclusion of all pairs of assessments into
the analyses regardless of how many assessments each
patient performed. QL difference scores of patients in a
Table 2
Ranking list of absolute paired differences (Δ) between subsequent
weighted satisfaction scores1 and retest correlations2
Quality of life domain Mean
Δ
Median
Δ
SD
Δ
Min–max
Δ
rtt
1. Breathing 4.9 5 4.4 0–23 .52
2. Complaints 4.8 5 5.0 0–32 .44
3. Digestion 4.7 5 4.8 0–21 .41
4. Partnership/sexuality 4.7 4 5.3 0–32 .65
5. Sleeping 4.7 3 5.3 0–32 .56
6. General health 4.6 4 5.0 0–24 .44
7. Daily routine 4.5 3 4.8 0–32 .43
8. Energy 4.4 3 4.6 0–24 .60
9. Eating 4.3 3 5.0 0–32 .56
10. Anxiety 4.2 4 3.9 0–24 .51
11. Leisure time/hobbies 4.1 3 4.4 0–22 .54
12. Physical condition 4.0 3 4.3 0–24 .58
13. Mobility 4.0 3 4.2 0–17 .59
14. Ability to relax 3.9 3 4.6 0–23 .55
15. Housing/living conditions 3.8 3 4.2 0–24 .73
16. Disadvantage 3.8 3 4.5 0–21 .62
17. Family 3.8 3 4.7 0–29 .64
18. Income/financial security 3.8 3 4.5 0–24 .55
19. Independence from help/care 3.8 3 4.3 0–24 .58
20. Occupation/work 3.8 3 4.6 0–24 .55
21. Understanding by others 3.6 3 3.9 0–20 .61
22. Being needed by others 3.5 3 3.6 0–16 .64
23. Adherence 3.5 3 4.2 0–22 .68
24. Friends/acquaintances 3.4 3 3.9 0–17 .50
25. Vision/hearing 3.4 3 4.0 0–23 .56
Sumscores
General life satisfaction 18.9 15 16.4 0–79 .74
Health-related life satisfaction 20.1 15 18.9 0–97 .72
CF-related life satisfaction 25.2 20 19.6 0–94 .68
1n=314 paired assessments; 2Pearson coefficients.
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than 10% of the predicted) were compared with QL scores of
patients with a clinical significant loss of pulmonary function
(decrease of FEV1N10% of the predicted) by repeated mea-
sures analyses of variance (ANOVAR), the interaction effect
of group (stable vs. instable patients) and time (first and
second assessment) was taken to test for different trajectories
of QL in both groups. To explore the partial impact of
different medical, treatment and psychosocial variables inde-
pendently of each other, a multiple regression analysis with
the QL sum-score across all life domains as dependent vari-
able was performed. With regard to the exploratory character
of this study, we used an iterative strategy of multiple re-
gression analysis. First, we run a multiple regression analysis
with 16 independent variables which were considered rel-
evant according to the literature. For the final regression
model we excluded stepwise those variables without sig-
nificant contribution to the explanation of variance of QL
(pN .15). This exclusion process was done twice (forward
and backward). In the final model only those 6 factors are
included which were consistently correlated to QL at T2
across both primary analyses. All statistical analyses were
done using the software package SYSTAT 10.2®.
3. Results
3.1. Feasibility
The completion time for the individual QL assessments
ranged from 5 to 29 min with a median of 11 min (SD=4.4).
According to the feedback from patients and staff, the
acceptance of the method was good, and both the computer-
assisted version and the paper–pencil version were consid-
ered practicable. This was also indicated by the absence of
any missing data. After initial instructions provided by the
CF nurses who were responsible for the assessment at the
outpatient clinics, the patients were able to fill in the
questionnaires without further assistance. Once enrolled in
the study, only one patient did not want to repeat the QL
assessments during the ongoing observation period.
3.2. Changes in quality of life
Each individual course of QL was analysed in episodes of
two subsequent assessments. The intra-individual difference
between both time points was determined for each weighted
QL score. A ranking list according to the variability of
weighted satisfaction in different life domains is provided in
Table 2. It can be seen that weighted satisfaction scores were
relatively stable in social domains such as friends/acquain-
tances, perceived understanding by others, being needed by
others or family, whereas most intra-individual variability
occurred in the health-related domains breathing, digestion,
general complaints, and in partnership/sexuality.
Longitudinal single case analyses of courses with more
than four assessments (see Fig. 1 for a case example) dem-onstrated an oscillation of QL scores around an individual
mean, with several peaks in both directions, but without a
general trend of increasing or decreasing QL. As can be seen
in Fig. 1, the intra-individual variance of QL is larger than
the patient's variance in FEV1, and the course of QL is
apparently independent from the course of FEV1.
Paired retest correlations (Pearson coefficients) for the
different QL dimensions were on a medium to high level with
rtt between .41 and .74 (see Table 2). The length of the
interval between assessments correlated neither with absolute
nor with relative intra-individual difference scores of QL.
3.3. Determinants of quality of life
A repeated measures analysis of variance (ANOVAR)
with two time points (T1, T2) demonstrated no main effect of
time on QL. Paired difference scores of FEV1% and QL were
not significantly correlated.
The comparison between those patients who showed a
clinical significant decrease of their pulmonary function
between two subsequent assessments (defined as a loss of
10% of the predicted FEV1 or more) and those patients in a
stable health status demonstrated a more negative course of
Table 3
Results of multiple regression analysis predicting the quality of life sum-
score1
Independent variables Standard
coefficient
t p
Previous QL .69 11.7 b .001
Interval between assessments .13 2.3 .025
New colonization with
Pseudomonas aeruginosa
.09 1.6 .117
Exacerbation of infection .14 2.5 .013
Partnership status .13 2.2 .032
Household independent from parents − .20 −3.5 .001
Vocation (none/part-time/full-time) − .16 −2.9 .005
Multiple R2 .74
1n=98; df=7/94; after stepwise exclusion of non-significant independent
variables from the model (criterion pb .15).
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the following domains: breathing (F=7.1, p=.008), sum-
score of health-related life satisfaction (F=4.8, p= .029),
independence from help/care (F=5.4, p=.020), income/fi-
nancial security (F=6.7, p=.010), and leisure time/hobbies
(F=5.6, p= .019).
A multiple regression analysis was performed to
determine the relative contribution of the different medical,
treatment, socio-demographic and psychosocial factors on
QL as measured with the FLZM. We chose the weighted life
satisfaction sum-score at T2 as the response variable and
included all factors with a significance of pb .15 in the final
regression model (see Table 3). This cutoff significance level
for inclusion of a factor was chosen with regard to the
explorative character of this study and to minimize type II
errors considering the relative small sample size and the
fact that some events such as new colonization with P.
aeruginosa were rare in our study sample and could there-
fore not reach high significance levels in its prediction of QL.
QL at T1 was included as a factor to control for the indi-
vidual QL baseline level. Neither age, gender, level of
education, FEV1% at T2, changes in FEV1% between T1 and
T2, BMI, time for daily therapy, oxygen therapy, status of
colonization with P. aeruginosa, nor recent i.v. antibiotic
therapy met the criterion of pb .15 for the significance of the
partial correlation with QL within the multiple regression
model. Compared with all other explanatory variables, pre-
vious QL had the strongest effect in predicting present QL.
Additionally the following six factors contributed signifi-
cantly to the prediction of QL at T2: the length of the interval
between the assessments, vocation, partnership status, living
separately from parents, acquisition of P. aeruginosa bet-
ween T1 and T2, and acute exacerbation of infection. The
multiple coefficient of determination (R2) reflects the amount
of variation in the response variable that can be explained by
the explanatory variables. Within the final regression model,
45% of the variance of life satisfaction was determined byFig. 1. Case example of a 22-year old female with CF based on 15
reassessments of quality of life and FEV1%.previous QL, and the above mentioned six factors explained
another 29% of the variance of QL. The direction of the
effects in determining QL was as follows: the longer the
interval between assessments, the better the QL at second
assessment. Full-time occupation was associated with poorer
QL compared with part-time or no occupation. Patients with
a partner reported better QL than patients without partner.
Living in a household separate from the parents was as-
sociated with lower QL than living together with the parents.
Recent colonization of P. aeruginosa or acute exacerbation
of infection had an independent negative effect on QL within
the model.
4. Discussion
This longitudinal study of a heterogeneous sample of
adolescent and adult CF patients was done within a natu-
ralistic design. The results are based on data from typical
patients with CF being treated according to international
clinical guidelines [39].
The feasibility of the FLZM for measuring QL in an
outpatient population is demonstrated by its broad accep-
tance by patients and staff, by the completeness of the col-
lected data, and by the shortness and convenience of the
assessment procedure, which can be done either by computer
administration or by paper and pencil.
The most prominent findings with regard to the longi-
tudinal analyses are the stability of QL, indicated by the
medium to high level retest correlations, the lack of sig-
nificant general time effects on QL in a positive or negative
direction, and the independence of QL and pulmonary func-
tion (with respect to level as well as change of function). The
previous personal level of QL predicted most of the variance
of re-assessed QL. Single case analyses with many repeated
assessments demonstrate that individual QL curves oscillate
around a personal average level. These findings are con-
sistent with the Australian study on children and adolescents
with CF by Sawyer et al. [35,36] who also demonstrated
stability of QL over a 2 year-period. Many different expla-
nations for this tendency are possible. Most patients may
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periencing a decrease in their subjectively perceived QL.
This phenomenon of adjusting the subjective estimation of
one's QL has also been referred to as response shift [40,41].
Moreover, QL may be considered rather a trait than a state
and therefore the personality of the patients may have a
greater impact on their QL than changes in their health status
or in their personal living circumstances. More longitudinal
studies are needed to investigate the possible mediating or
moderating effects of coping and personality on QL.
Besides the personal level of QL which is represented by
moderate retest correlations, six additional factors were
demonstrated to contribute to the prediction of QL with CF
by our exploratory multiple regression analyses: From a set
of socio-demographic variables, partnership and closeness to
the parents even in adulthood could be identified as pro-
tective factors. These factors indicate the availability of
social support for the patients, and the protective effect of
social support in buffering a potential negative impact of
chronic diseases is known from previous studies [42,43]. On
the other hand, a full-time vocation seems to conflict with
QL, indicating that CF patients with limited time resources
due to their daily therapy regime and limited physical re-
sources due to their impaired objective health status may pay
a certain price for their job engagement.
In accordance with the previous findings [19,26,27], the
differential effects of the medical and disease-related
variables in this study demonstrate that infection exacerba-
tions and being newly colonized with P. aeruginosa have an
impact on QL whereas the level of pulmonary function
(FEV1%) and body mass index do not. Only patients with a
clinical significant decrease of their pulmonary function,
defined as a minimum loss of 10% of the predicted FEV1,
show worse QL trajectories in some domains compared to
patients with stable FEV1. These findings may be explained
by the different impacts of acute symptoms compared with
slowly progressing symptoms. Stress and coping theory
postulates that it is more difficult to adapt to acute stressors
than to changes which proceed slowly, as acute stressors
strain the coping capacity of the individual [44].
The positive correlation of interval between assessments
and level of QL can be explained by a less severe disease.
The interval between QL assessments in this study was
determined by the frequency of pulmonary function tests
within the observation period. Frequent pulmonary function
tests probably indicate a more severe disease. Especially in
the case of decreasing pulmonary function therapists would
try to prescribe a more aggressive therapy (for example,
additional courses of antibiotic i.v. treatment) and they
would consequently evaluate the effects of treatment by
repeated pulmonary function tests.
Additionally, the knowledge of being free from potential
dangerous germs may help the patients to maintain an op-
timistic view of their lives. Most of the patients in our study
were well educated with regard to their CF, and they were
aware of their prognosis worsening with the acquisition ofspecifically pathogenic germs. Only 16% of the patients
were free from P. aeruginosa at the beginning of the study.
Once colonized, these patients would probably expect a
progression of their disease, and therefore they may perceive
a worse QL by anticipating a negative course of their disease.
The following limitations of this study have to be ac-
knowledged, entailing a cautious interpretation of the results.
First, the sample size of this pilot study did not allow for the
analysis of a more comprehensive set of risk and protection
factors. The statistical power of the analyses was limited, and
only strong or moderate effects could be detected. Other
variables that were not included in this study may also have a
significant impact on the patients' QL.
Secondly, only outpatients were included in this study.
Therefore our results cannot be generalized to patients in a
very critical medical condition who are often hospitalized.
Third, the non-standardized time schedule for reassess-
ments of QL may have affected the results of our study.
Although it would be hard to realize in clinical routine,
standardized intervals of QL may lead to different results.
For example, assessments every 6 or 12 months independent
of the measurement of pulmonary function would allow us to
take a glimpse of the patient's subjective health estimation
more regularly.
Another limitation of this study is that the FLZM was not
consistently completed prior to the other clinical examina-
tions. In most cases the patients answered the questions
during the waiting time before their clinical appointment, but
sometimes the assessment was done after information on
present clinical data such as the results of the pulmonary
function test. This information may have systematically
influenced the QL ratings, and future studies should strictly
use a certain order of assessment.
5. Conclusions
The results of our longitudinal analyses provide further
evidence that QL is predominantly independent of slow
changes in pulmonary function. Clinicians should take into
account the fact that the patients' perceptions of their
personal situation may depend more on their personal style
of living with the disease, individual coping strategies, and
available social support than on pulmonary function. On
the other hand, infection exacerbations and the coloniza-
tion status with problematic germs such as P. aeruginosa
should be considered relevant medical parameters for the
patients' QL.
With little additional effort it would be possible to mon-
itor QL in outpatient clinical routine as demonstrated in this
study. Especially the computer-assisted assessment with its
options of immediate analyses and automatic documentation
of individual results can facilitate the implementation into
clinical routine. Multiple benefits of such a procedure for the
patients can be expected. In times of downsizing health care
budgets it becomes increasingly important for the therapists
to recognize the patients' situation adequately within the
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and standardized QL assessments would easily provide
additional information on the effects of changes in individual
treatment schedules, on unexpected changes in the patients'
subjective health perception or on potential special needs
arising from a difficult social situation that may reduce
adherence to treatment. Those patients who are not used to
communicating their subjective health-related perceptions to
their therapists spontaneously may be enabled to report their
personal situation in a more comprehensive way than when
responding to global “how are you?” questions. Taking QL
into account may allow therapists to understand more deeply
their patients' subjective health-related cognitions. This
would enhance the integration of the patients' subjective
perspective into the process of shared decision making.
Future studies should evaluate different methods and designs
for monitoring QL and the effect of the immediate feedback
of assessment results on patient–therapist communication.
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